Discovery of long-acting N-(cyanomethyl)-N-alkyl-L-prolinamide inhibitors of dipeptidyl peptidase IV

Bioorg Med Chem. 2008 Jan 1;16(1):190-208. doi: 10.1016/j.bmc.2007.10.005. Epub 2007 Oct 5.

Abstract

Details of structure-activity relationships (SAR) for P2 moiety of a P1 2-cyanopyrrolidine dipeptidyl peptidase IV (DPP-IV) inhibitor 4a including stereochemistry are presented. Based on this information, a series of P1 (N-alkyl)aminoacetonitrile analogs 9-20 possessing optimal P2 structure were synthesized and evaluated as inhibitors of DPP-IV. Among them, a representative compound 11, N-(cyanomethyl)-N-ethyl-L-prolinamide, was further evaluated to determine its effect on the plasma glucose level. Also 4a, 10, and 11 were evaluated for their isozyme selectivity to predict their safety problems.

MeSH terms

  • Blood Glucose / drug effects
  • Dipeptidyl Peptidase 4
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Enzyme Inhibitors / chemistry
  • Humans
  • Proline / analogs & derivatives*
  • Proline / chemistry
  • Proline / pharmacology
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Blood Glucose
  • Dipeptidyl-Peptidase IV Inhibitors
  • Enzyme Inhibitors
  • Proline
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4
  • prolinamide